BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8662113)

  • 1. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging.
    Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Ida K; Sugihara H; Takeda K; Nakagawa M
    Eur J Nucl Med; 1996 Jul; 23(7):756-61. PubMed ID: 8662113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of hypertensive hypertrophy in which both regression of hypertrophy and improvement of the abnormalities in iodine-123-metaiodobenzylguanidine (MIBG) myocardial imagings were observed after antihypertensive therapy].
    Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Sugihara H; Takeda K
    Kaku Igaku; 1995 Oct; 32(10):1107-12. PubMed ID: 8523833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy.
    Kuwahara T; Hamada M; Hiwada K
    J Nucl Med; 1998 Sep; 39(9):1486-91. PubMed ID: 9744329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac sympathetic nervous system in early essential hypertension assessed by 123I-MIBG.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Nucl Med; 1999 Jan; 40(1):6-11. PubMed ID: 9935049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload.
    Imamura Y; Ando H; Ashihara T; Fukuyama T
    J Am Coll Cardiol; 1996 Aug; 28(2):371-5. PubMed ID: 8800112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-123-metaiodobenzylguanidine myocardial imaging in patients with right ventricular pressure overload.
    Morimitsu T; Miyahara Y; Sinboku H; Ikeda S; Naito T; Nishijima K; Takao M
    J Nucl Med; 1996 Aug; 37(8):1343-6. PubMed ID: 8708768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.
    Mitani I; Sumita S; Takahashi N; Ochiai H; Ishii M
    Ann Nucl Med; 1996 Aug; 10(3):315-21. PubMed ID: 8883707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy.
    Giordano A; Melina G; Calcagni ML; Schinzari F; Cirillo F; Mettimano M; Cardillo C; Melina D
    Arch Med Res; 2007 Jul; 38(5):512-8. PubMed ID: 17560456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy].
    Narita M; Kurihara T
    J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial adrenergic nerve activity in valvular diseases assessed by iodine-123-metaiodobenzylguanidine myocardial scintigraphy].
    Imamura Y; Fukuyama T
    J Cardiol; 1997; 29 Suppl 2():21-6. PubMed ID: 9211099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].
    Terada K; Sugihara H; Shiga K; Ohtsuki K; Ito K; Taniguchi Y; Azuma A; Kohno Y; Miyao K; Nakagawa M
    J Cardiol; 1995 May; 25(5):247-53. PubMed ID: 7776194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial imaging with 123I-metaiodobenzylguanidine in essential hypertension and renovascular hypertension.
    Ohya Y; Sasaki M; Fujishima S; Kagiyama S; Onaka U; Kaseda S; Ohmori S; Kuwabara Y; Abe I; Fujishima M
    Clin Exp Hypertens; 2001 May; 23(4):293-304. PubMed ID: 11349821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of cardiac sympathetic neuronal and left ventricular function in chronic mitral regurgitation: assessment by iodine-123 metaiodobenzylguanidine scintigraphy.
    Tsutsui H; Ando S; Kubota T; Kuroiwa-Matsumoto M; Egashira K; Sasaki M; Kuwabara Y; Koyanagi S; Yasui H; Takeshita A
    Am J Card Imaging; 1996 Jan; 10(1):14-22. PubMed ID: 8680129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effect of an L/N-type calcium channel blocker in patients with hypertensive heart disease.
    Kosaka T; Nakagawa M; Ishida M; Iino K; Watanabe H; Hasegawa H; Ito H
    J Cardiol; 2009 Oct; 54(2):262-72. PubMed ID: 19782264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.
    Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Nakajima K; Taki J; Mabuchi H
    J Nucl Med; 2002 Jan; 43(1):15-20. PubMed ID: 11801697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of myocardial sympathetic nerve function in patients with mitral valve prolapse using iodine-123-metaiodobenzylguanidine myocardial scintigraphy].
    Kishi F; Nomura M; Yukinaka M; Saito K; Tabata T; Iuchi A; Fukuda N; Oki T; Ito S; Nakaya Y
    J Cardiol; 1996; 27 Suppl 2():21-8; discussion 29-30. PubMed ID: 9067814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
    Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
    J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of insulin resistance by troglitazone ameliorates cardiac sympathetic nervous dysfunction in patients with essential hypertension.
    Watanabe K; Komatsu J; Kurata M; Inaba S; Ikeda S; Sueda S; Suzuki J; Kohara K; Hamada M
    J Hypertens; 2004 Sep; 22(9):1761-8. PubMed ID: 15311105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure.
    Kurata C; Wakabayashi Y; Shouda S; Okayama K; Yamamoto T; Ishikawa A; Suzuki K; Ishizuka T; Sakamoto S; Tawarahara K
    J Nucl Med; 1995 Nov; 36(11):2037-43. PubMed ID: 7472594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.